Xiamen Amoytop Biotech Co., Ltd.SSE: 688278

Report for Q1 2025

Apr 23, 2025 · Issued by Xiamen Amoytop Biotech Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Apr 23, 2025

On 6ix: 6ix.com/news/report-for-q1-2025-403

Report for Q1 2025

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Xiamen Amoytop Biotech Co., Ltd. on 6ix

Earlier from Xiamen Amoytop Biotech

Announcement on Resolution of the 2024 Annual General MeetingApr 19, 2025
Announcement on Attending Annual Collective Performance Briefing for STAR Market Enterprises in Biological Products and CXO Industries in 2024Apr 16, 2025
Announcement on Provision of Online Voting Reminder Service for General MeetingApr 11, 2025
2024 Annual ReportMar 28, 2025

Later from Xiamen Amoytop Biotech

Announcement on Implementation of 2024 Annual Dividend DistributionApr 30, 2025
Announcement on Attending the 2024 Annual Report Performance Briefing and Online Collective Reception Day for Investors of Listed Companies in Xiamen JurisdictionMay 8, 2025
Indicative Announcement on Negotiated Transfer of Some Shares and Equity Change by Shareholders Holding More Than 5% SharesMay 23, 2025
Announcement on the Approval of Yipei Growth Hormone Injection for MarketingMay 30, 2025
Announcement on Shareholder with Over 5% Shares Completing Registration for Negotiated Transfer of Some SharesJul 4, 2025

All Xiamen Amoytop Biotech news releases

Follow Xiamen Amoytop Biotech into a list and get an email when it puts out news.

Follow Xiamen Amoytop Biotech